| 1897 |
Marcel Mérieux creates the Institut Mérieux, which developed a large range of vaccines and biological products, including reagents. Alain Mérieux was president of the Institut for 25 years, until 1994.
|
1963
|
Creation of BD Mérieux equally owned by Institut Mérieux and Becton Dickinson.
|
| 1974 |
Alain Mérieux takes majority control of the company: BD Mérieux becomes bioMérieux.
|
| 1986 |
API Systems (France) acquisition.
|
| 1988 |
Vitek acquisition from McDonnel Douglas (U.S.).
|
| 2001 |
Organon Teknika Diagnostic acquisition from Akzo Nobel (Netherlands).
|
| 2003 |
40th anniversary.
|
| 2004 |
Listing of bioMérieux on the stock exchange.
|
| 2006 |
Inauguration of the Christophe Mérieux Center, dedicated to molecular biology and microsystems research (Grenoble, France).
Bacterial Barcodes (U.S.) acquisition - DiversiLab™.
|
| 2007 |
Biomedics (Spain) acquisition.
BTF (Australia) acquisition.
|
| 2008 |
Joint venture with Sysmex (Japan).
Joint venture with Shanghai Kehua Bio-engineering (China).
AB BIODISK (Sweden) acquisition.
AviaraDx (U.S.) acquisition - renamed bioTheranostics, Inc.
|
| 2009 |
Strategic partnership with the French Atomic Energy Commission (CEA).
|
| 2010 |
Acquisition of Meikang Biotech (China).
Acquisition of Shanghai Zenka Biotechnology (China).
|
| 2011 |
Acquisition of AES Laboratoire (France)
Acquisition of ARGENE (France) |